# Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury

> **NCT07093723** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 60 (actual)

## Conditions studied

- S100B
- Neutrophils/Lymphocytes Ratio
- Prediction
- Brain Injury

## Interventions

- **DIAGNOSTIC_TEST:** S100B Protein
- **DIAGNOSTIC_TEST:** Neutrophils to Lymphocytes ratio

## Key facts

- **NCT ID:** NCT07093723
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07093723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07093723, "Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07093723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*